Chief Financial Officer And Company Secretary
CurrentLateral Pharma owns all of the intellectual property associated with the peptide AOD9604 which has potential applications in the treatment pain and migraine illness.There is a significant unfulfilled need for a new, safe and effective treatment for pain that may be addressed by AOD9604.I report to the Board and CEO. My responsibilities include the full.